Correction of subclinical ascorbate deficiency in patients receiving dialysis: effects on plasma oxalate, serum cholesterol, and capillary fragility.

[1]  C. Tomson,et al.  The determination of plasma oxalate concentrations using an enzyme/bioluminescent assay. 2. Co-immobilisation of bioluminescent enzymes and studies of in vitro oxalogenesis. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[2]  C. Tomson,et al.  The Clinical Significance of Hyperoxalaemia , 1988, The International journal of artificial organs.

[3]  R. Watts,et al.  Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxine. , 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  J. M. Simpson,et al.  Plasma oxalate in patients receiving continuous ambulatory peritoneal dialysis. , 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  W. Schreurs,et al.  Deficiencies of vitamins in CAPD patients: the effect of supplementation. , 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  B. Agroyannis,et al.  Re-evaluation of Ascorbic Acid Deficiency in Hemodialysed Patients , 1987, The International journal of artificial organs.

[7]  P. Chamberlain,et al.  Immunologic competence of hemodialysis patients following withdrawal of vitamin C supplement. , 1987, Nephron.

[8]  H. W. Boyce,et al.  Longitudinal follow-up of chronic hemodialysis patients without vitamin supplementation. , 1986, Kidney international.

[9]  M. Morimatsu,et al.  Should vitamin C supplementation be restricted in regular hemodialysis patients? , 1986, ASAIO transactions.

[10]  M. Levine.  New concepts in the biology and biochemistry of ascorbic acid. , 1986, The New England journal of medicine.

[11]  F. Marumo,et al.  Deranged Concentrations of Water-Soluble Vitamins in the Blood of Undialyzed and Dialyzed Patients with Chronic Renal Failure , 1986, The International journal of artificial organs.

[12]  C. Kjellstrand,et al.  Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients. , 1985, Nephron.

[13]  J. Crosson,et al.  Acute oxalate nephropathy after massive ascorbic acid administration. , 1985, Archives of internal medicine.

[14]  McAllister Cj.  Spontaneous fistula between a right common iliac artery and iliac vein. , 1984 .

[15]  C. J. Mcallister,et al.  Renal failure secondary to massive infusion of vitamin C. , 1984, JAMA.

[16]  A. Shenkin,et al.  Vitamin Status in Continuous Ambulatory Peritoneal Dialysis , 1984 .

[17]  J. Wesley,et al.  Hyperoxaluria and renal insufficiency due to ascorbic acid administration during total parenteral nutrition. , 1984, Annals of internal medicine.

[18]  A. Pönkä,et al.  Serum ascorbic acid in patients undergoing chronic hemodialysis. , 2009, Acta medica Scandinavica.

[19]  G. Sander,et al.  Vitamin nutrition in patients on continuous ambulatory peritoneal dialysis (CAPD). , 1983, Clinical nephrology.

[20]  R. Chesney,et al.  Secondary oxalosis as a complication of parenteral alimentation in acute renal failure. , 1983, American journal of nephrology.

[21]  K. Paletas,et al.  Effect of peritoneal dialysis on plasma levels of ascorbic acid. , 1983, Nephron.

[22]  A. Truswell,et al.  High intakes of ascorbic acid and urinary oxalate. , 1981, Journal of human nutrition.

[23]  E. Ginter.  Marginal vitamin C deficiency, lipid metabolism, and atherogenesis. , 1978, Advances in lipid research.

[24]  D. Bradley,et al.  Plasma and whole blood concentrations of ascorbic acid in patients undergoing long-term hemodialysis. , 1973, American journal of clinical pathology.

[25]  D. Bradley,et al.  Comparison of ascorbic acid concentrations in whole blood obtained by venipuncture or by finger prick. , 1972, Clinical chemistry.

[26]  A. Eisenstein,et al.  Ascorbic acid depletion during hemodialysis. , 1972, JAMA.

[27]  T. P. Eddy,et al.  A study of the relationship between Hess tests and leucocyte ascorbic acid in a clinical trial , 1972, British Journal of Nutrition.

[28]  H. Sauberlich,et al.  Metabolism of 14C- and 3H-labeled L-ascorbic acid in human scurvy. , 1971, American Journal of Clinical Nutrition.

[29]  H. Sauberlich,et al.  Clinical manifestations of ascorbic acid deficiency in man. , 1971, American Journal of Clinical Nutrition.

[30]  A. Eisenstein,et al.  Ascorbic acid depletion in patients undergoing chronic hemodialysis. , 1970, The American journal of clinical nutrition.

[31]  R. Watts,et al.  QUANTITATIVE ASPECTS OF ASCORBIC ACID METABOLISM IN MAN. , 1964, The Journal of biological chemistry.

[32]  A. Goldberg.  The anaemia of scurvy. , 1963, The Quarterly journal of medicine.

[33]  L. Hellman,et al.  Metabolism of L-ascorbic acid-1-C14 in man. , 1958, The Journal of biological chemistry.